IOPtima Ltd. has developed the IOPtiMate system;
a unique laser based surgical system for the treatment of
Glaucoma. The system utilizes a CO2 laser technology to reduce
internal eye pressure by allowing better flow of aqueous humor.
In utilizing the particular properties of the CO2 laser, the IOPtiMate
thins the sclera wall via ablating surges at the normal eye
drainage area (Schlemm’s Canal region), in a simple and highly
controlled and specific manner. The IOPtiMate is highly effective in ablating dry tissue, and allows the surgeon to thin the sclera by gradually removing, layer by layer, most of the scleral tissue, leaving a thin intact layer which transforms the
safety of the procedure to a higher level. The remaining layer is thin enough to allow the internal eye fluid to percolate through, thus relieving the eye of the inner excessive pressure. Because infrared CO2 laser radiation is absorbed and blocked by nature by aqueous solutions, the laser energy does not penetrate into the eye. Thereforethe remaining thin scleral layer remains intact, reducing the likelihood of surgery complications, adverse events and side effects.
“This elegant self-regulated procedure is possible because the IOPtiMate system is designed to achieve functional, simple, safe, reproducible and optimal results from surgery, with minimal side effects and reduced recovery time. At the same time, the procedure is highly efficacious, with a minimal learning curve”